Study S000266
Efficacy, Safety and Treatment Satisfaction of Once Weekly Tirzepatide in Obese Type 2 Diabetic Patients at a Tertiary Care Centre
Registration
Registered primary outcomes
- Change in Glycemic Control (HbA1c) [Baseline, 3 months, and 6 months]
- Change in Body Weight [Baseline and monthly up to 6 months]
Linked records (0)
Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.
No records link to this registration yet.